Labcorp Holdings (LH) Cost of Revenue (2016 - 2025)
Historic Cost of Revenue for Labcorp Holdings (LH) over the last 17 years, with Q3 2025 value amounting to $2.5 billion.
- Labcorp Holdings' Cost of Revenue rose 676.31% to $2.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $9.8 billion, marking a year-over-year increase of 749.08%. This contributed to the annual value of $9.4 billion for FY2024, which is 668.21% up from last year.
- Per Labcorp Holdings' latest filing, its Cost of Revenue stood at $2.5 billion for Q3 2025, which was up 676.31% from $2.5 billion recorded in Q2 2025.
- Labcorp Holdings' 5-year Cost of Revenue high stood at $2.7 billion for Q3 2021, and its period low was $328.2 million during Q4 2021.
- For the 5-year period, Labcorp Holdings' Cost of Revenue averaged around $2.2 billion, with its median value being $2.3 billion (2024).
- As far as peak fluctuations go, Labcorp Holdings' Cost of Revenue tumbled by 8730.32% in 2021, and later surged by 54948.2% in 2022.
- Quarter analysis of 5 years shows Labcorp Holdings' Cost of Revenue stood at $328.2 million in 2021, then soared by 549.48% to $2.1 billion in 2022, then rose by 3.77% to $2.2 billion in 2023, then increased by 10.0% to $2.4 billion in 2024, then rose by 4.33% to $2.5 billion in 2025.
- Its Cost of Revenue was $2.5 billion in Q3 2025, compared to $2.5 billion in Q2 2025 and $2.4 billion in Q1 2025.